WNK2 and idiopathic pulmonary fibrosis: In the normal cell line, changes were related to signaling associated with the anti-tumor drug, daunorubicin, while the changes in the IPF derived fibroblasts were associated with Mitogen-Activated Protein Kinases (MAPK) processes (Fig 2B).